Gainers
- Marker Therapeutics MRKR stock moved upwards by 121.9% to $0.73 during Friday's pre-market session. The market value of their outstanding shares is at $61.2 million.
- Athenex ATNX stock increased by 60.34% to $1.01. The company's market cap stands at $122.8 million.
- Joint JYNT stock rose 21.27% to $24.45. The company's market cap stands at $353.5 million. As per the news, the Q2 earnings report came out yesterday.
- Evofem Biosciences EVFM stock rose 18.04% to $1.06. The market value of their outstanding shares is at $37.5 million. The company's, Q2 earnings came out yesterday.
- Kazia Therapeutics KZIA shares rose 17.84% to $2.09. The market value of their outstanding shares is at $29.1 million.
- Sensus Healthcare SRTS shares increased by 13.65% to $12.65. The market value of their outstanding shares is at $210.9 million. The company's, Q2 earnings came out yesterday.
Losers
- Quoin Pharmaceuticals QNRX stock decreased by 23.5% to $10.76 during Friday's pre-market session. The market value of their outstanding shares is at $8.6 million.
- Nektar Therapeutics NKTR stock declined by 19.69% to $3.55. The market value of their outstanding shares is at $661.2 million. As per the press release, Q2 earnings came out yesterday.
- Chembio Diagnostics CEMI shares declined by 18.31% to $0.88. The market value of their outstanding shares is at $26.6 million. As per the press release, Q2 earnings came out yesterday.
- Allena Pharma ALNA stock declined by 17.57% to $0.13. The market value of their outstanding shares is at $13.8 million.
- Doximity DOCS shares declined by 16.9% to $33.5. The company's market cap stands at $6.4 billion. As per the news, the Q1 earnings report came out yesterday.
- Exicure XCUR stock declined by 16.0% to $2.1. The company's market cap stands at $10.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in